J K Łacki

817 total citations
52 papers, 652 citations indexed

About

J K Łacki is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, J K Łacki has authored 52 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 17 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Immunology. Recurrent topics in J K Łacki's work include Systemic Lupus Erythematosus Research (21 papers), Rheumatoid Arthritis Research and Therapies (18 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). J K Łacki is often cited by papers focused on Systemic Lupus Erythematosus Research (21 papers), Rheumatoid Arthritis Research and Therapies (18 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). J K Łacki collaborates with scholars based in Poland, Switzerland and United States. J K Łacki's co-authors include S Mackiewicz, Agnieszka Paradowska‐Gorycka, Piotr Leszczyński, Wernér E.G. Müller, E Wojtecka-Lukasik, B. Wojciechowska, S Maśliński, Daniel R. Altschuler, Paweł P. Jagodzińśki and Luis Álvarez-Gaumé and has published in prestigious journals such as Nuclear Physics B, Physics Letters B and Annals of the Rheumatic Diseases.

In The Last Decade

J K Łacki

48 papers receiving 604 citations

Peers

J K Łacki

IMMUN

RHEUM

ONCOL

RNMI

HEMAT

Jan Łącki Poland

Hirofumi Yamada Japan

Subramanya Hegde India

Hideo Shimada Japan

Yusuke Yamada Japan

Koichi Nagasaki Japan

Yuji Sugawara Japan

Ernestine Lee United States

Shitong Yu China

Martin Beránek Czechia

Jan Łącki Poland

J K Łacki

173 ×0.6

IMMUN

208 ×0.8

RHEUM

66 ×0.6

ONCOL

39 ×0.5

RNMI

47 ×0.7

HEMAT

Citations per year, relative to J K Łacki J K Łacki (= 1×) peers Jan Łącki

Countries citing papers authored by J K Łacki

Since Specialization

Citations

This map shows the geographic impact of J K Łacki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J K Łacki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J K Łacki more than expected).

Fields of papers citing papers by J K Łacki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J K Łacki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J K Łacki. The network helps show where J K Łacki may publish in the future.

Co-authorship network of co-authors of J K Łacki

This figure shows the co-authorship network connecting the top 25 collaborators of J K Łacki. A scholar is included among the top collaborators of J K Łacki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J K Łacki. J K Łacki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Przepiera‐Będzak, Hanna, et al.. (2011). Bone tissue metabolism in men with ankylosing spondylitis. Advances in Medical Sciences. 56(2). 264–269. 7 indexed citations

Więsik–Szewczyk, Ewa, J K Łacki, Wojciech Feleszko, & Marzena Olesińska. (2010). Target Therapies in Systemic Lupus Erythematosus: Current State of the Art. Mini-Reviews in Medicinal Chemistry. 10(10). 956–965. 5 indexed citations

Piotrowski, Piotr, Margarita Lianeri, Mariusz Wudarski, J K Łacki, & Paweł P. Jagodzińśki. (2010). CD24 Ala57Val gene polymorphism and the risk of systemic lupus erythematosus. Tissue Antigens. 75(6). 696–700. 14 indexed citations

Paradowska‐Gorycka, Agnieszka, et al.. (2010). Interleukin‐10 gene promoter polymorphism in Polish rheumatoid arthritis patients. International Journal of Immunogenetics. 37(4). 225–231. 26 indexed citations

Piotrowski, Piotr, Margarita Lianeri, Mariusz Wudarski, et al.. (2009). The CD3Z 844 T>A polymorphism within the 3′‐UTR of CD3Z confers increased risk of incidence of systemic lupus erythematosus. Tissue Antigens. 74(1). 68–72. 11 indexed citations

Pazdur, J, et al.. (2007). The effect of methylprednisolone on proliferation of PBMCs obtained from steroid‐sensitive and steroid‐resistant rheumatoid arthritis patients. Scandinavian Journal of Rheumatology. 36(3). 167–171. 24 indexed citations

Łacki, J K, et al.. (2001). [Bone tissue metabolism in systematic lupus erythematosus patients treated with glucocorticosteroids].. PubMed. 106(4). 901–7. 1 indexed citations

Łacki, J K, et al.. (2000). TNF-? gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatology International. 19(4). 137–140. 33 indexed citations

Łacki, J K, et al.. (1997). Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.. PubMed. 28(1-2). 99–107. 45 indexed citations

10.

Łacki, J K, et al.. (1997). Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clinical Rheumatology. 16(3). 275–278. 73 indexed citations

11.

Łacki, J K, et al.. (1997). The effect of methotrexate and azathioprine on the serum levels of IgA-<FONT FACE=Symbol>a</FONT>1-antitrypsin complex in juvenile chronic arthritis. Brazilian Journal of Medical and Biological Research. 30(6). 763–767. 1 indexed citations

12.

Łacki, J K, S Mackiewicz, Piotr Leszczyński, & Wernér E.G. Müller. (1997). The effect of intravenous cyclophosphamide pulse on peripheral blood lymphocytes in lupus erythematosus patients. Rheumatology International. 17(2). 55–60. 18 indexed citations

13.

Łacki, J K, et al.. (1997). Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Lung Cancer. 16(2-3). 273–274. 51 indexed citations

14.

Łacki, J K, et al.. (1996). The Lymphocyte Phenotype in Patients with Primary Fibromyalgia. Upsala Journal of Medical Sciences. 101(3). 251–256. 2 indexed citations

15.

Łacki, J K, et al.. (1996). Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs.. PubMed. 27(2). 47–51. 1 indexed citations

16.

Łacki, J K, et al.. (1995). Interleukin 10 inhibits interleukin 6 production and acute phase response in rheumatoid arthritis.. PubMed. 43(1). 11–4. 8 indexed citations

17.

Łacki, J K, et al.. (1994). Comparison of microheterogeneity of alpha-1-acid-glycoprotein in serum and synovial fluid from rheumatoid arthritis patients. Clinical Rheumatology. 13(4). 598–604. 8 indexed citations

18.

Łacki, J K & Krzysztof Wiktorowicz. (1994). [Biological properties of interleukin 10].. PubMed. 48(4). 363–70. 3 indexed citations

19.

Łacki, J K. (1989). Algèbres de dimension infinie, groupes des tresses et groupes quantiques dans les théories conformes à deux dimensions. Rivista Del Nuovo Cimento. 12(12). 1–52. 5 indexed citations

20.

Altschuler, Daniel R., et al.. (1988). The affine Weyl group and modular invariant partition functions. Physics Letters B. 205(2-3). 281–284. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact